HIV Part II Flashcards
All NRTI AE
- Lactic acidosis
- Hepatic steatosis
- Lipodystrophy (fat breakdown)
Zidovudine (ZDV) AE
- Headache
- Bone marrow suppression
- GI intolerance
- Lipoatrophy
Can still be used in preggo (Delivery) and kids
ABC AE
- Hypersensitivity (HLA-B*5701)
- Rash
- Possible increased risk of MI
TAF/TDF AE
- Renal impairment (TDF> TAF)
- Decreased BMD (TDF > TAF)
- Headache (most common)
- GI intolerance
- TAF has no lipid benefits
All INSTI AE
- Rash, hypersensitivity
- Depression and suicidal ideation
Both VERY rare
Dolutegravir AE
- Headache (lasts about a week)
- Insomnia** (take in morning)
Elvitegravir (EVG/c) AE
- Decreased CrCl
- Increased risk of TDF-related nephrotoxicity when combined
- Nausea, diarrhea
Raltegravir AE
- Nausea
- Headache
- Diarrhea
- CPK elevation, myopathy, rhabdomyolysis
ALL PI AE
- Hyperlipidemia
- Lipodystrophy
- Hepatotoxicity
- GI intolerance
- Possible bleeding risk in hemophiliacs
- DDI (all PI due to boosters)
More common with older PIs
Atazanavir (ATV) AE
- Hyperbilirubinemia
- PR Prolongation
- Nephrolithiasis, cholelithiasis
- Less likely to cause lipid abnormalities
Darunavir (DRV) AE
- Rash
- Liver Toxicity
Ritonavir AE
- GI intolerance
- Hyperlipidemia
- Hyperglycemia
- Hepatitis
Cobicistat AE
- GI intolerance
- Increased SCr
All NNRTI AE
- Rash (including SJS)
- Hepatotoxicity (especially with NPV, only used in kids with possible HIV at birth)
- DDI
EFV AE
- Neuropsychiatric
- Teratogenic + cases of neural tube defects in human infants (category D)
- Dyslipidemia
Etravirine (ETR) AE
Nausea
Rilpivirine (RPV) AE
- Depression
- Insomnia
Maraviroc AE
- DDI
- Rash
- Abdominal pain
- Upper respiratory tract infection
- Cough
- Hepatotoxicity
- Musculoskeletal symptoms
- Orthostatic hypotension, esp in renally compromised
(Not HIV specific so large amount of SE)
Enfuvirtide AE
- Injection site reactions
- Hypersensitivity reactions
- Increased risk of bacterial pneumonia
Atazanavir + Acid Requirement
- Separate by 2 hours from antacids
- Take 2 hours before or 10 hours after H2RAs
- Don’t use with PPIs, can separate by 12 hours if absolutely needed
Rilpivirine + Acid Requirement
- CI with PPI
- Separate H2RAs by 12 hours
Lipid Agents + HIV Drugs
- Simvastatin and Lovastatin are CI with PIs or delavirdine
- Pravastatin and fluvastatin and least likely to interact with ARVs
- Use atorvastatin at low doses with caution (never go to 80 mg)
- Rosuvastatin should be started at low doses and increased slowly as drug interactions with PIs are documented
Antifungals + HIV Drugs
- Ketoconazole and EFV use is CI
- Decrease doses of EFV and voriconazole if used together
- Fluconazole can increase doses of some drugs (ETR, NVP, RPV, and ZDV), monitor while given but adjustment not needed
- Increase caspofungin with certain HIV drugs
Corticosteroids + HIV Drugs
- PK boosters increase levels of steroids and leads to Cushing’s Syndrome
- Beclomethasone is the only exception
- NNRTIs can decrease many [steroid]
- Dexamethasone can decrease concentrations of many HIV meds like NNRTIs, PIs, and cobi-based regimens. CI with rilpivirine
M184V Mutation
- Most common NRTI mutation
- High-level in vitro resistance to 3TC/FTC but not CI
- Mutation increases TDF, AZT, and d4T susceptibility and decreases viral replication fitness
K103N Mutation
- Common NNRTI mutation
- Resistance to EFV, NVP
- Most spread from person to person
K65R Mutation
- Major mutation to ABC and TDF resistance
- DDI and decreased susceptibility to 3TC, FTC, and d4T
- Can’t use a nucleotide backbone anymore
HIV Transmission + Pregnancy
- Most occurs close to or during delivery
- 15-30% risk of transmission without treatment from mother to fetus
- With ART, C-section, and formula feeding the risk drops to <1%
HIV Regimen + Pregnancy
- During pregnancy: ART
- During labor: ART +/- IV ZDV (if VL > 1000, can consider 50-1000 too), begin when admitted or 3 hours before c-section
- Post-partum Mothers: Continue ART
- Newborn: PO ZDV
PEP Regimen
-TDF/FTC 1 QD
PLUS
-Raltegravir 400 mg BID or Dolutegravir 50 mg daily
-Duration: 4 weeks
PrEP
- Truvada 1 PO daily (men and women)
- Descovy 1 PO daily (men only)
- Preventing transmission when sexually active with high risk individuals